iiinova — where your digital self keeps evolving

Onco404

@onco404.bsky.social

193 followers 642 following 762 posts

Your resource dedicated to personalized cancer care: Curated news, key scientific articles, and analyses.

Posts Replies Media

Reposted by Onco404

Ünal Metin Tokat @umtokat.bsky.social · 09/09/2025

actr.amegroups.org/article/view...

actr.amegroups.org

Post-CDK4/6i wars in HR+/HER2− breast cancer: is elacestrant a solid contender through the lens of precision oncology

Post-CDK4/6i wars in HR+/HER2− breast cancer: is elacestrant a solid contender through the lens of precision oncology

Onco404 @onco404.bsky.social · 03/07/2025

📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer. #Onco404 #Cancer #Kanser #Oncology #GeriatricOncology #Oncogeriatrics #CancerCare #MedSky #OncSky #MedNews #Vocabulary

Onco404 @onco404.bsky.social · 27/06/2025

📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer. #Onco404 #Cancer #Kanser #Oncology #CancerAwareness #CancerCare #ParaneoplasticSyndrome #PNS #MedSky #OncSky #Vocabulary

Onco404 @onco404.bsky.social · 26/06/2025

📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer. #Onco404 #Cancer #Kanser #Oncology #MedSky #OncSky #CancerAwareness #InvestigationalNewDrug #IND #FDA #ClinicalTrials #Vocabulary

Onco404 @onco404.bsky.social · 30/05/2025

The TuPro study used 9 #multiomics technologies (scRNA-seq, proteomics, etc.) to profile 116 #melanoma patients, generating >40,000 markers/sample in just 4 weeks. @natureportfolio.nature.com #Onco404 #Cancer #Kanser #PrecisionOncology #ClinicalTrials #TumorProfiling #MedSky #OncSky #ASCO2025

Onco404 @onco404.bsky.social · 30/05/2025

📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer. #Onco404 #Cancer #Kanser #MedSky #OncSky #CancerAwareness #CancerCare #Chemokine #ImmuneSystem #ImmuneResponse #TumorImmunity #Vocabulary

Onco404 @onco404.bsky.social · 29/05/2025

This integrated analysis of CodeBreaK 100 & 200 trials delves into biomarkers influencing sotorasib efficacy in KRAS G12C-mutated NSCLC. #NatureMedicine #Onco404 #Cancer #Kanser #LungCancer #Sotorasib #NSCLC #Biomarkers #PrecisionOncology #KRAS #TTF1 #KEAP1 #NRF2 #NFE2L2 #MedSky #OncSky

Onco404 @onco404.bsky.social · 29/05/2025

📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer. #Onco404 #Cancer #Kanser #CancerAwareness #Cytokine #ImmuneSystem #CancerCare #Inflammation #MedSky #OncSky #Vocabulary

Onco404 @onco404.bsky.social · 28/05/2025

A cluster randomized trial tested if algorithm-based EHR defaults with accountable justification could increase specialty palliative care (PC) consultations. @JAMANetworkOpen #JAMA #Onco404 #Cancer #Kanser #Hospice #PalliativeCare #SupportiveCare #MedSky #OncSky #Healthcare #DigitalHealth

Onco404 @onco404.bsky.social · 28/05/2025

📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer. #Onco404 #Cancer #Kanser #CancerAwareness #Hospice #YaşamSonuBakımı #PalliativeCare #PalyatifBakım #QoL #MedSky #OncSky #Vocabulary

Onco404 @onco404.bsky.social · 27/05/2025

A new study analyzed 233 trials associated with 207 FDA approvals (2015–2020) and found alarming gaps in health-related quality of life (HRQoL) reporting. #BMJ #BMJOncology #Onco404 #Cancer #Kanser #Oncology #ClinicalTrials #FDA #QoL #HRQoL #MedSky #OncSky #PatientReportedOutcomes

Onco404 @onco404.bsky.social · 27/05/2025

📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer. #Onco404 #Cancer #Kanser #MedSky #OncSky #PatientCenteredCare #CancerCare #QualityOfLife #QoL #PatientReportedOutcomes #PROs #Vocabulary

Onco404 @onco404.bsky.social · 26/05/2025

The phase III MITO-23 trial compared trabectedin monotherapy to physician’s choice chemo in 244 patients with BRCA-mutated or BRCAness recurrent ovarian cancer. @ascocancer.bsky.social #JCO #ASCO #Onco404 #Cancer #Kanser #OvarianCancer #MedSky #OncSky #BRCA #BRCAness #Trabectedin #ClinicalTrials

Onco404 @onco404.bsky.social · 26/05/2025

📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer. #Onco404 #Cancer #Kanser #MedSky #OncSky #BRCAness #HRD #BRCA1 #BRCA2 #PlatinumChemotherapy #PARPInhibitor #TargetedTherapy #Vocabulary

Onco404 @onco404.bsky.social · 26/05/2025

📌 "OncoTerm - Word of the Day" - WEEKLY DIGEST (May 19-25)👋 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer. #Onco404 #OncoTerm #Oncology #Cancer #Kanser #CancerAwareness #Healthcare #FightCancer #MedSky #OncSky #Vocabulary

Onco404 @onco404.bsky.social · 26/05/2025

📌 “OncoTerm - Günün Kelimesi” - HAFTALIK ÖZET (19-25 Mayıs) 👋 Kansere karşı mücadelede kendimizi bilgiyle güçlendirmek için temel terimleri açıklarken bize katılın. #Onco404 #OncoTerm #Oncology #Cancer #Kanser #CancerAwareness #Healthcare #FightCancer #Vocabulary

Onco404 @onco404.bsky.social · 25/05/2025

This phase II study assessed encorafenib + binimetinib (BRAFi/MEKi), followed by the addition of a third targeted agent based on genomic alterations at progression @theaacr.bsky.social #CCR #Onco404 #Cancer #Kanser #Melanoma #TargetedTherapy #ClinicalTrials #BRAF #PrecisionMedicine #MedSky #OncSky

Onco404 @onco404.bsky.social · 25/05/2025

This May, Onco404 honors every unique journey touched by melanoma and skin cancer 🏅 Every step forward, every shared story, fuels our collective hope 🕊️ You are not alone 🖤 #Onco404 #Cancer #Kanser #Melanoma #MelanomaAwarenessMonth #SkinCancerAwarenessMonth #Hope #MedSky #OncSky

Onco404 @onco404.bsky.social · 25/05/2025

📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer. #Onco404 #Cancer #Kanser #CancerAwareness #CancerPrevalence #CancerPrevention #CancerScreening #PublicHealth #Healthcare #Vocabulary

Onco404 @onco404.bsky.social · 24/05/2025

The final analysis of the INTRIGUE phase III trial reveals ripretinib and sunitinib show comparable overall survival in advanced GIST patients post-imatinib. @ascocancer.bsky.social #JCO #ASCO #Onco404 #Cancer #Kanser #GIST #Ripretinib #Sunitinib #ClinicalTrials #MedSky #OncSky

Onco404 @onco404.bsky.social · 24/05/2025

📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer #Onco404 #Cancer #Kanser #CancerAwareness #Incidence #CancerIncidence #CancerPrevention #CancerScreening #PublicHealth #MedSky #Vocabulary

Onco404 @onco404.bsky.social · 23/05/2025

📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer. #Onco404 #Cancer #Kanser #TP53 #LiFraumeniSyndrome #CancerPrevention #Sarcoma #BreastCancer #Leukemia #BrainTumors #ACC #Vocabulary

Onco404 @onco404.bsky.social · 22/05/2025

The CAPP2 trial (long-term follow-up) reveals that 600 mg aspirin daily for ≥2 years cuts colorectal cancer (CRC) risk in Lynch syndrome patients by 35% 💊 #Lancet #Onco404 #Cancer #Kanser #ClinicalTrials #LynchSyndrome #ColorectalCancer #EndometrialCancer #Aspirin #CancerPrevention #MedSky #OncSky

Onco404 @onco404.bsky.social · 22/05/2025

📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer. #Onco404 #Cancer #Kanser #CancerAwareness #LynchSyndrome #RiskFactor #ColorectalCancer #EndometrialCancer #MedSky #OncSky #Vocabulary

Onco404 @onco404.bsky.social · 21/05/2025

A 2019 Global Burden of Disease Study reveals 44.4% of cancer deaths (4.45M) were linked to modifiable risk factors. @thelancet.com #Onco404 #Cancer #Kanser #PublicHealth #HalkSağlığı #CancerPrevention #GlobalHealth #Healthcare #RiskFactors #MedSky #OncSky

Onco404 @onco404.bsky.social · 21/05/2025

📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer. #Onco404 #cancer #kanser #cancerawareness #riskfactor #medsky #oncsky #smoking #alcohol #obesity #genetics #familyhistory #vocabulary

Onco404 @onco404.bsky.social · 20/05/2025

The phase 3 #IMPower151 trial evaluated atezolizumab + bevacizumab + CT (ABCPem/Pac) vs bevacizumab + CT (BCPem/Pac) in 305 Chinese pts with metastatic nsqNSCLC #NatureMedicine @natureportfolio.nature.com #Onco404 #Cancer #Kanser #LungCancer #Immunotherapy #ClinicalTrials #PrimaryEndpoint #MedSky

Onco404 @onco404.bsky.social · 20/05/2025

📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer. #Onco404 #Cancer #Kanser #Cancerawareness #ClinicalTrials #KlinikAraştırma #ClinicalEndpoint #MedSky #OncSky #Endpoint #Vocabulary

Onco404 @onco404.bsky.social · 19/05/2025

The phase 1b #Zongertinib trial delivers promising results for patients with previously treated HER2-mutant #NSCLC @nejm.org #Onco404 #Cancer #Kanser #MedSky #OncSky #LungCancer #AkciğerKanseri #HER2 #TargetedTherapy #ClinicalTrials

Onco404 @onco404.bsky.social · 19/05/2025

📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer. #Onco404 #Cancer #Kanser #MedSky #ClinicalTrials #Healthcare #PhaseTrials #DrugDevelopment #PatientOutcomes #Innovation #Vocabulary

Onco404 @onco404.bsky.social · 19/05/2025

📌 “OncoTerm - Günün Kelimesi” - HAFTALIK ÖZET (12-18 Mayıs) 👋 Kansere karşı mücadelede kendimizi bilgiyle güçlendirmek için temel terimleri açıklarken bize katılın. #Onco404 #OncoTerm #Oncology #Cancer #Kanser #MedSky #OncSky #CancerAwareness #Healthcare #FightCancer #Vocabulary

Onco404 @onco404.bsky.social · 19/05/2025

📌 "OncoTerm - Word of the Day" - WEEKLY DIGEST (May 12-18)👋 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer. #Onco404 #OncoTerm #Oncology #Cancer #Kanser #MedSky #OncSky #CancerAwareness #Healthcare #FightCancer #Vocabulary

Onco404 @onco404.bsky.social · 18/05/2025

This study explores patient-reported outcomes #PROs for patients with previously treated #SCLC receiving #Tarlatamab, a bispecific T-cell engager binding #DLL3 and #CD3 @natureportfolio.nature.com #Onco404 #Cancer #Kanser #LungCancer #ClinicalTrials #Immunotherapy #BispesificAntibody #MedSky

Onco404 @onco404.bsky.social · 18/05/2025

📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer. #Onco404 #Cancer #Kanser #CancerAwareness #BispecificAntibody #Immunotherapy #Blinatumomab #Blincyto #Amivantamab #Rybrevant #Vocabulary

Onco404 @onco404.bsky.social · 17/05/2025

This study evaluated GPT-4o, Llama 3.1, and Qwen 2.5 for classifying cancer genetic variants from OncoKB, CIViC, and a real-world #FoundationOne #CDx dataset. @natureportfolio.nature.com #Onco404 #Cancer #Kanser #PrecisionOncology #AI #MedSky #OncSky #Genomics #LLM #CompanionDiagnostics

Onco404 @onco404.bsky.social · 17/05/2025

📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer. #Onco404 #Cancer #Kanser #MedSky #OncSky #ImmunogenicCellDeath #ICD #Immunotherapy #Recurrence #Vocabulary

Onco404 @onco404.bsky.social · 16/05/2025

Further analysis of the RUBY trial (Part 1) focuses on patients with dMMR/MSI-H primary advanced or recurrent EC, highlighting the consistent benefits of adding dostarlimab to CT. @GynecologicOncology #Onco404 #Cancer #Kanser #Immunotherapy #EndometrialCancer #dMMR #MSI #Dostarlimab

Onco404 @onco404.bsky.social · 16/05/2025

📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer. #Onco404 #Cancer #Kanser #MedSky #ImmuneCheckpointInhibitor #Immunotherapy #Keytruda #Opdivo #Yervoy #Imfinzi #Jemperli #Vocabulary

Onco404 @onco404.bsky.social · 15/05/2025

The phase II LUMINOSITY trial evaluated telisotuzumab vedotin (Teliso-V) in advanced c-Met protein-overexpressing, nonsquamous EGFR-wildtype NSCLC. @ascocancer.bsky.social #JCO #Onco404 #Cancer #Kanser #LungCancer #AkciğerKanseri #MedSky #OncSky #PrecisionMedicine #ClinicalTrials #cMET #ADC

Onco404 @onco404.bsky.social · 15/05/2025

📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer. #Onco404 #Cancer #Kanser #MedSky #AntibodyDrugConjugate #ADC #Enhertu #Trodelvy #Padcev #Kadcyla #Elahere #Mylotarg #Polivy #Vocabulary

Onco404 @onco404.bsky.social · 14/05/2025

A 10-gene signature can now predict recurrence risk for HR+/HER2- early breast cancer #EBC patients post-chemo-endocrine therapy. @myesmo.bsky.social @breastcancerorg.bsky.social #Onco404 #Cancer #Kanser #BreastCancer #MemeKanseri #OncotypeDX #MammaPrint #EndoPredict #Prosigna #PAM50 #GGI #MedSky

Onco404 @onco404.bsky.social · 14/05/2025

📌 OncoTerm - Word of the Day! 👋 📌 OncoTerm - Günün Kelimesi! 👋 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer. #Onco404 #Cancer #Kanser #CancerAwareness #TumorDormancy #Dormancy #Dormansi #Relapse #Recurrence #Nüks #MedSky #OncSky #Vocabulary

Onco404 @onco404.bsky.social · 13/05/2025

A recent study highlights bispecific antibodies #BsAbs as a powerful bridging therapy before BCMA CAR-T cell treatment for relapsed/refractory multiple myeloma #RRMM @theaacr.bsky.social #bcd_aacr #Onco404 #Cancer #Kanser #MultipleMyeloma #CARTCellTherapy #MedSky #Immunotherapy #Hematology

Onco404 @onco404.bsky.social · 13/05/2025

📌 OncoTerm - Word of the Day! 👋 📌 OncoTerm - Günün Kelimesi! 👋 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer. #Onco404 #Cancer #Kanser #MedSky #OncSky #MyeloidDerivedSuppressorCell #MDSC #TumorMicroenvironment #TME #Vocabulary

Onco404 @onco404.bsky.social · 12/05/2025

This long-term analysis of the ShortHER trial (10-year data, 866 pts) highlights the crucial role of tumor-infiltrating lymphocytes #TILs in ERBB2-positive early breast cancer. @jama.com @bccroc.bsky.social #Onco404 #Cancer #Kanser #BreastCancer #MemeKanseri #ERBB2 #HER2 #MedSky #OncSky

Onco404 @onco404.bsky.social · 12/05/2025

📌 OncoTerm - Word of the Day! 👋 📌 OncoTerm - Günün Kelimesi! 👋 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer. #Onco404 #Cancer #Kanser #CancerAwareness #CancerAssociatedFibroblasts #CAF #TumorMicroenvironment #TME #MedSky #OncSky #Vocabulary

Onco404 @onco404.bsky.social · 12/05/2025

📌 "OncoTerm - Word of the Day" - WEEKLY DIGEST (May 5-11)👋 Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer. #Onco404 #OncoTerm #Oncology #Cancer #Kanser #CancerAwareness #Healthcare #FightCancer #MedSky #OncSky #Vocabulary

Onco404 @onco404.bsky.social · 12/05/2025

📌 “OncoTerm - Günün Kelimesi” - HAFTALIK ÖZET (5-11 Mayıs) 👋 Kansere karşı mücadelede kendimizi bilgiyle güçlendirmek için temel terimleri açıklarken bize katılın. #Onco404 #OncoTerm #Oncology #Cancer #Kanser #CancerAwareness #Healthcare #FightCancer #MedSky #OncSky #Vocabulary

Onco404 @onco404.bsky.social · 11/05/2025

If headaches persist, vision shifts, or thoughts feel foggy: Don’t ignore the whispers! Behind every statistic is a person, a story, a fight worth supporting 🎗️Together, let’s amplify hope 🤍🩶🖤 #Onco404 #Cancer #Kanser #BeyinKanseri #BrainCancerAwarenessMonth #GoGrayInMay #Hope #GBM #MedSky #OncSky

Onco404 @onco404.bsky.social · 11/05/2025

This prospective trial evaluated #Atezolizumab with standard radiation/TMZ in newly diagnosed #Glioblastoma #GBM patients, identifying pre-treatment features linked to survival. @natcomms.nature.com #Onco404 #Cancer #Kanser #Immunotherapy #BrainTumor #PrecisionOncology #MedSky #OncSky